Slamon; Dennis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Slamon; Dennis.The latest application filed is for "kras g12c inhibitors and uses thereof".

Company Profile

5.1.14

Slamon; Dennis - Los Angeles CA
Slamon; Dennis - Woodland Hills CA
Slamon; Dennis - Oakland CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Kras G12c Inhibitors And Uses Thereof App 20220227738 - Hilf; Justin A. ; et al.	2022-07-21
Prmt5 Inhibitors And Uses Thereof App 20220194949 - O'Boyle; Brendan M. ; et al.	2022-06-23
Claudin-6 Bispecific Antibodies App 20220177583 - Conklin; Dylan ; et al.	2022-06-09
Claudin-6 Antibodies And Drug Conjugates App 20220162299 - Conklin; Dylan ; et al.	2022-05-26
Cdk Inhibitors And Uses Thereof App 20220106325 - O'Boyle; Brendan M. ; et al.	2022-04-07
Erk Inhibitors And Uses Thereof App 20220002294 - Reeves; Corey M. ; et al.	2022-01-06
Methods And Materials For Assessing And Treating Cancer App 20210355545 - Velculescu; Victor E. ; et al.	2021-11-18
Claudin6 Antibodies And Methods Of Treating Cancer App 20200291111 - Conklin; Dylan ; et al.	2020-09-17
Biomarkers of Response to Cyclin D-CDK4/6 Targeted Therapies in Cancer App 20190292605 - Slamon; Dennis ; et al.	2019-09-26
Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer App 20190048424 - Slamon; Dennis ; et al.	2019-02-14
Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer App 20170369950 - Slamon; Dennis ; et al.	2017-12-28
Biomarkers of Response to Cyclin D-CDK4/6 Targeted Therapies in Cancer App 20170067116 - Slamon; Dennis ; et al.	2017-03-09
Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer App 20160138114 - Slamon; Dennis ; et al.	2016-05-19
Constraints-based analysis of gene expression data App 20050079508 - Dering, Judy ; et al.	2005-04-14
Treatment of platelet derived growth factor related disorders such as cancers Grant 5,990,141 - Hirth , et al. Nov	1999-11-23

Company Registrations

SEC

0001603265

Slamon Dennis

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.